57 related articles for article (PubMed ID: 30678455)
1. The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation.
Kötter B; Frey B; Winderl M; Rubner Y; Scheithauer H; Sieber R; Fietkau R; Gaipl US
Radiat Oncol; 2015 Sep; 10():197. PubMed ID: 26383236
[TBL] [Abstract][Full Text] [Related]
2. Effect of covalent photoconjugation of affibodies to epidermal growth factor receptor (EGFR) on cellular quiescence.
Roy S; Curry SD; Bibbey MG; Chapnick DA; Liu X; Goodwin AP; Cha JN
Biotechnol Bioeng; 2022 Jan; 119(1):187-198. PubMed ID: 34676884
[TBL] [Abstract][Full Text] [Related]
3. Ras-Targeting Stabilized Peptide Increases Radiation Sensitivity of Cancer Cells.
Qin W; Wei X; Yang D; Luo Q; Huang M; Xing S; Wei W; Liang L; Huang J; Zhou Z; Lu F
Bioconjug Chem; 2024 May; ():. PubMed ID: 38738511
[TBL] [Abstract][Full Text] [Related]
4. Functional Nanomedicines for Targeted Therapy of Bladder Cancer.
Tang C; Liu H; Fan Y; He J; Li F; Wang J; Hou Y
Front Pharmacol; 2021; 12():778973. PubMed ID: 34867408
[TBL] [Abstract][Full Text] [Related]
5. Modulating the Radiation Response for Improved Outcomes in Breast Cancer.
Pesch AM; Pierce LJ; Speers CW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250414
[No Abstract] [Full Text] [Related]
6. The Effect of PEI-Mediated E1A on the Radiosensitivity of Hepatic Carcinoma Cells.
Xu D; Yao J; Zhang Y; Xiao N; Peng P; Li Z; Pan Z; Yao Z
Asian Pac J Cancer Prev; 2020 Apr; 21(4):911-917. PubMed ID: 32334450
[TBL] [Abstract][Full Text] [Related]
7. Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab.
Smith TA; Cheyne RW
Br J Biomed Sci; 2011; 68(3):158-66. PubMed ID: 21950209
[TBL] [Abstract][Full Text] [Related]
8. Daphnoretin Arrests the Cell Cycle and Induces Apoptosis in Human Breast Cancer Cells.
Xie Q; Fan X; Han Y; Wu BX; Zhu B
J Nat Prod; 2022 Oct; 85(10):2332-2339. PubMed ID: 36154031
[TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells.
Yao Z; Peng P; Xu D; Zhou X; Pan Z; Li Z; Yao J; Chen J
Asian Pac J Cancer Prev; 2019 Jan; 20(1):311-319. PubMed ID: 30678455
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
[TBL] [Abstract][Full Text] [Related]
11. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
[TBL] [Abstract][Full Text] [Related]
12. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway.
Tan B; Huang Y; Zhang B; Lin N
Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
14. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S
BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562
[TBL] [Abstract][Full Text] [Related]
15. Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy.
Takada S; Sagawa T; Fujikawa K; Tahatsu K; Fukai Y; Hashishita H; Takahashi Y; Endo M
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2325-2330. PubMed ID: 30141310
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
